4-methyl-1-cyclohexen-1-ylboronic acid
Product Information
Molecular Formula
C7H13BO2
Molecular Weight
139.99
Description
4-methyl-1-cyclohexen-1-ylboronic acid occupies a pivotal position as an elemental unit for concocting diverse pharmacological agents. Its foremost purpose revolves around combating specific ailments encompassing cancer and inflammation. This paramount substance underscores its indispensability in propelling biomedical investigation and fostering pioneering breakthroughs in drug exploration.
Synonyms
4-Methylcyclohexen-1-ylboronic acid; (4-METHYLCYCLOHEX-1-EN-1-YL)BORONIC ACID; 4-METHYL-1-CYCLOHEXEN-1-YLBORONIC ACID; (4-methylcyclohexen-1-yl)boronic acid; Boronic acid, (4-methyl-1-cyclohexen-1-yl)-; 4-METHYLCYCLOHEX-1-ENYLBORONIC ACID; 4-methyl cyclohexen-1-ylboronic acid; 4-methylcyclohexen-1-yl boronic acid; (4-methyl-1-cyclohexen-1-yl)boronic acid; 4-methyl-1-cyclohexen-1-ylboronic acid
IUPAC Name
(4-methylcyclohexen-1-yl)boronic acid
SMILES
B(C1=CCC(CC1)C)(O)O
InChI
InChI=1S/C7H13BO2/c1-6-2-4-7(5-3-6)8(9)10/h4,6,9-10H,2-3,5H2,1H3
InChI Key
SJZMIZIVYIOMIW-UHFFFAOYSA-N
Flash Point
Not applicable
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
1
Exact Mass
140.1008598 g/mol
Monoisotopic Mass
140.1008598 g/mol
Topological Polar Surface Area
40.5Ų
Heavy Atom Count
10
Formal Charge
0
Complexity
143
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
1
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| JP-2022021687-A | Method for Producing N-Substituted (Meta) Acrylamide | 2020-07-22 |
| CA-3054300-A1 | Curable and solvent soluble formulations and methods of making and using thereof | 2017-02-22 |
| EP-3585824-A2 | Curable and solvent soluble formulations and methods of making and using thereof | 2017-02-22 |
| US-2020062877-A1 | Curable and Solvent Soluble Formulations and Methods of Making and Using Therof | 2017-02-22 |
| WO-2018156766-A2 | Curable and solvent soluble formulations and methods of making and using thereof | 2017-02-22 |
| AU-2017251537-A1 | Bromodomain inhibitors | 2016-04-15 |
| EP-3442972-A1 | Bromodomain inhibitors | 2016-04-15 |
| KR-20180134350-A | Bromo domain inhibitor | 2016-04-15 |
| US-10633379-B2 | Bromodomain inhibitors | 2016-04-15 |
| US-2019345153-A1 | Bromodomain Inhibitors | 2016-04-15 |
